Abstract
Primary cutaneous large B cell lymphoma, leg type (PCLBCL-leg) has recently been identified and recognized as a specific entity. Patients with PCLBCL-leg have a higher relapse rate and a poorer prognosis than the other types of primary cutaneous B cell lymphomas, and disease relapse is confined to the skin in the majority of cases with rare exclusive extracutaneous progression. The late occurrence of lymphoma in patients with a prior history of lymphoma may represent a relapse/progression or a distinct tumor unrelated to the original one. The distinction is of important clinical and therapeutic implications. Here, we report the case of a 90-year-old lady with a history of PCLBCL-leg in complete remission after radiotherapy that developed a huge, solitary pulmonary lymphoma without lymphadenopathy 14 months later. The latter was initially considered as stage IE primary pulmonary lymphoma and was treated with combination chemotherapy resulting in complete remission. Retrospective pathologic review and B cell clonality study revealed that the pulmonary tumor was a diffuse large B cell lymphoma of the same clonal origin as the PCLBCL-leg. This case is unique in the exclusive pulmonary relapse and illustrates the importance of expert pathological review and molecular study in the management of lymphoma patients with unusual clinical features.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29:252–60.
Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768–85.
Vermeer MH, Geelen FA, van Haselen CW, van Voorst Vader PC, Geerts ML, van Vloten WA, et al. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group. Arch Dermatol. 1996;132:1304–8.
Grange F, Bekkenk MW, Wechsler J, Meijer CJ, Cerroni L, Bernengo M, et al. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study. J Clin Oncol. 2001;19:3602–10.
Goodlad JR, Krajewski AS, Batstone PJ, McKay P, White JM, Benton EC, et al. Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypes. Am J Surg Pathol. 2003;27:1538–45.
Zinzani PL, Quaglino P, Pimpinelli N, Berti E, Baliva G, Rupoli S, et al. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for cutaneous lymphomas. J Clin Oncol. 2006;24:1376–82.
Nishiuchi R, Yoshino T, Teramoto N, Sakuma I, Hayashi K, Nakamura S, et al. Clonal analysis by polymerase chain reaction of B-cell lymphoma with late relapse: a report of five cases. Cancer. 1996;77:757–62.
Libra M, De Re V, Gasparotto D, Gloghini A, Marzotto A, Milan I, et al. Differentiation between non-Hodgkin’s lymphoma recurrence and second primary lymphoma by VDJ rearrangement analysis. Br J Haematol. 2002;118:809–12.
Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–82.
Chuang SS, Lin CN, Shen FC, Liao PJ, Liao YL, Chang JH, et al. Detecting clonal rearrangement in non-Hodgkin’s lymphomas in Taiwan by polymerase chain reaction. Leuk Lymphoma. 2003;44:117–21.
Liao JB, Chuang SS, Chen HC, Tseng HH, Wang JS, Hsieh PP. Clinicopathologic analysis of cutaneous lymphoma in Taiwan: a high frequency of extranodal NK/T-cell lymphoma, nasal type, with an extremely poor prognosis. Arch Pathol Lab Med. 2010 (in press).
Willemze R. Primary cutaneous B-cell lymphoma: classification and treatment. Curr Opin Oncol. 2006;18:425–31.
Begueret H, Vergier B, Parrens M, Lehours P, Laurent F, Vernejoux JM, et al. Primary lung small B-cell lymphoma versus lymphoid hyperplasia: evaluation of diagnostic criteria in 26 cases. Am J Surg Pathol. 2002;26:76–81.
Kim JH, Lee SH, Park J, Kim HY, Lee SI, Park JO, et al. Primary pulmonary non-Hodgkin’s lymphoma. Jpn J Clin Oncol. 2004;34:510–4.
Hu YH, Hsiao LT, Yang CF, Chiou TJ, Liu JH, Gau JP, et al. Prognostic factors of Chinese patients with primary pulmonary non-Hodgkin’s lymphoma: the single-institute experience in Taiwan. Ann Hematol. 2009;88:839–46.
Shioyama Y, Nakamura K, Kunitake N, Kimura M, Terashima H, Masuda K. Relapsed non-Hodgkin’s lymphoma: detection and treatment. Radiat Med. 2000;18:369–75.
Libra M, De Re V, Gloghini A, Navolanic PM, Carbone A, Boiocchi M. Second primary lymphoma or recurrence: a dilemma solved by VDJ rearrangement analysis. Leuk Lymphoma. 2004;45:1539–43.
Matolcsy A, Schattner EJ, Knowles DM, Casali P. Clonal evolution of B cells in transformation from low- to high-grade lymphoma. Eur J Immunol. 1999;29:1253–64.
Chang ST, Chuang SS, Wang YH. Polyostotic primary bone lymphoma with progression limited in the skeleton: Identical clonal origin of the initial and progressed tumors and a late relapse by VDJ rearrangement analysis. Leuk Lymphoma. 2006;47:1144–8.
Chuang SS, Liu H, Huang Y, Chio CC, Lin LC. Primary cerebral diffuse large B-cell lymphoma relapsed solely in the skin with the same clonal origin. Appl Immunohistochem Mol Morphol. 2009;17:77–81.
Acknowledgments
This work was supported by the research fund CMNSC9801 from Chi-Mei Medical Center, Tainan, Taiwan.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Chen, YF., Li, YC., Chen, LM. et al. Primary cutaneous diffuse large B cell lymphoma relapsed solely as a huge lung tumor mimicking a primary pulmonary lymphoma. Int J Hematol 91, 112–116 (2010). https://doi.org/10.1007/s12185-009-0455-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-009-0455-6